Kinnate Biopharma Inc. Quarterly Current Ratio in % from Q3 2021 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kinnate Biopharma Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q4 2023.
  • Kinnate Biopharma Inc. Current Ratio for the quarter ending December 31, 2023 was 1.17K %, a 34.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 1.17K -624 -34.8% Dec 31, 2023
Q3 2023 1.19K -821 -40.8% Sep 30, 2023
Q2 2023 1.33K -887 -40% Jun 30, 2023
Q1 2023 1.55K -806 -34.2% Mar 31, 2023
Q4 2022 1.79K -858 -32.3% Dec 31, 2022
Q3 2022 2.01K -1.46K -42.1% Sep 30, 2022
Q2 2022 2.22K Jun 30, 2022
Q1 2022 2.36K Mar 31, 2022
Q4 2021 2.65K Dec 31, 2021
Q3 2021 3.47K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.